Posts

Roche Partners with Nvidia for Pharma's Largest AI Factory, Surpassing Eli Lilly

Roche announced on March 16, 2026, an expansion of its Nvidia partnership, adding 2,176 Blackwell GPUs to create the pharmaceutical industry's largest hybrid-cloud AI factory with over 3,500 GPUs total. The AI factory spans U.S. and Europe sites, accelerating therapeutics, diagnostics, drug discovery, manufacturing, digital pathology, and digital health. It builds on a 2023 Genentech-Nvidia collaboration and supports Roche's 'Lab-in-the-Loop' strategy using Nvidia BioNeMo. This eclipses Eli Lilly's recent Nvidia supercomputer, positioning Roche as leader in AI-driven pharma innovation. Quotes from Roche executives highlight embedding AI across the value chain to speed up medicine and diagnostic delivery. Sources:

Rhythm Pharmaceuticals' Imcivree Succeeds in Phase 3 for Hypothalamic Obesity, Contrary to Failure Reports, with PDUFA Date Approaching

Aldeyra Therapeutics' Reproxalap Faces FDA PDUFA Extension to March 16, 2026 After Third Review Delay, Sparking Stock Concerns

Pfizer's Atirmociclib Delivers Positive Phase 2 Results in Metastatic Breast Cancer

Astellas Ends Partnership with CytomX Despite Positive Phase 1 Data for Probody Platform

Field Medical Names Dr. Mark A. Turco as New CEO

Unnatural Products Secures Novartis Partnership Worth Up to $1.8 Billion for Macrocyclic Peptide Therapeutics in Cardiovascular Disease

CytomX Announces Positive Phase 1 Data for Varsetatug Masetecan in Late-Line Colorectal Cancer

Structure Therapeutics Reports Strong Phase 2 ACCESS II Data for Oral GLP-1 Aleniglipron with 16% Weight Loss

Federal Judge Blocks RFK Jr.'s Childhood Vaccine Policy Overhaul

Recludix Pharma Promotes Executive Leaders Following Recent Corporate Accomplishments

Roche Launches NVIDIA AI Factory with 2,176 Additional Blackwell GPUs, Achieving Pharma's Largest Infrastructure

Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates